MedPath

MINT-QUETIAPINE XR

MINT-QUETIAPINE XR

Dormant
DIN Number

02522225

Drug Class

Human

Market Date

Oct 4, 2022

Company
HC

mint pharmaceuticals inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02522225
AIG Number0131858007
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
N05AH04 QUETIAPINE
Product Specifications
Dosage FormTablet (Extended-Release)
Route of AdministrationOral
AHFS Classification28:16.08.04
Health Canada Classification

ACTIVE INGREDIENTS (1)

QUETIAPINE (QUETIAPINE FUMARATE)Active
Strength: 400 MG
Monograph: QUETIAPINE (QUETIAPINE FUMARATE)

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.